Opening Asia for Russia

Japan is preparing to vaccinate the population

14.02.2021 101 просмотров

Pfizer has become the first coronavirus vaccine approved in Japan.


Japan's Ministry of Health, Labor and Welfare on Sunday approved the use of a coronavirus vaccine made by American pharmaceutical company Pfizer. This was announced by the Japanese authorities.

Pfizer's drug was the first to be approved for use in Japan. Earlier on Friday, an expert commission under the Japanese Ministry of Health also gave the go-ahead for the use of the Pfizer vaccine.

Vaccination in Japan is expected to begin in the second half of February and will take place in several stages. First of all, it will affect approximately 4 million medical and social workers. In the second phase, about 36 million people over 65 years of age will be vaccinated. Then the campaign will spread to 8.2 million residents of Japan with chronic diseases, and only by May the remaining categories of citizens will be able to receive vaccines. Last year, Japan signed agreements to supply COVID-19 vaccines with Pfizer, as well as the British-Swedish pharmaceutical company AstraZeneca (AstraZeneca) and the American biotech firm Moderna (Moderna).

Last year Japan has signed agreements for the supply of COVID-19 vaccines with Pfizer, as well as with the British-Swedish pharmaceutical company AstraZeneca (AstraZeneca) and the American biotechnology firm Moderna (Moderna). Vaccination in Japan for all local residents, including foreign citizens, will be free - for this, the country's parliament passed a special law at the end of last year.

Новости партнёров